Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cognoptix Inc.

www.cognoptix.com

Latest From Cognoptix Inc.

Alzheimer’s Disease: Moving Toward The Era Of Diagnostic Certainty

With more than 13 million people in the US expected to have Alzheimer’s disease (AD) by 2050, an increasing number of companies are focused on developing reliable AD diagnostics designed to facilitate early detection and treatment. Although the field remains in its relative infancy, researchers are gaining greater diagnostic certainty through a combination of diagnostic approaches, and over the next decade, the AD diagnostics market is projected to reach a US market value of at least $1 billion to $3 billion per year.

Medical Device Innovation

Medtech Execs On The Move, January 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Medtech Execs On The Move, November-December 2014

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Venture Funding Deals, November 2014

Derived from Strategic Transactions, a premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a  monthly review of emerging In Vitro  Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced September through October 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
    • Laser
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Neuroptix Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cognoptix Inc.
  • Senior Management
  • Paul Hartung, Pres. & CEO
    Tom Trometer, CFO
    Charles Kerbage, PhD, Dir., R&D
  • Contact Info
  • Cognoptix Inc.
    Phone: (978) 263-0005
    20 Main St.
    Acton, MA 01720
    USA
UsernamePublicRestriction

Register